AccScience Publishing / GTM / Volume 2 / Issue 4 / DOI: 10.36922/gtm.1361
Submit to GTM
Cite this article
105
Download
1768
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
REVIEW

Efficacy of ketogenic and low-carbohydrate diets in the management of Type 2 diabetes: A narrative review

Sabrina Zaman1 ,  Tamsel Ahammed1* ,  Md. Nazmul Haque1 ,  Md. Enamul Huque2
Show Less
1 Department of Nutrition and Food Technology, Faculty of Applied Science and Technology, Jashore University of Science and Technology, Jashore, Bangladesh
2 Department of Nutrition and Food Science, Institute of Nutrition and Food Science, University of Dhaka, Bangladesh
Global Translational Medicine 2023, 2(4), 1361 https://doi.org/10.36922/gtm.1361
Submitted: 24 July 2023 | Accepted: 17 October 2023 | Published: 14 December 2023
(This article belongs to the Special Issue Recent Advances in Macronutrient Metabolism )
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

Obesity and diabetes represent two prevalent metabolic challenges intricately linked to poor dietary habits and a sedentary lifestyle. The escalating incidence of both conditions in recent years has approached epidemic proportions, with concomitant associations observed in individuals with excessive body weight, including hypertension and cancer. In response to this growing health concern, treatment approaches such as food therapy are deemed necessary. A pivotal aspect in managing these conditions is the careful selection of an appropriate diet to facilitate effective weight loss while minimizing potential adverse effects. Consequently, the ketogenic diet (KD) has garnered attention and support in the treatment of obesity and diabetes. This review aims to discern the potential advantages and risks associated with the utilization of a low-carbohydrate diet in Type 2 diabetic patients. It is well-established that dietary choices significantly impact the health of diabetic patients, and therefore, adopting an appropriate diet is crucial. The KD has demonstrated positive effects on blood sugar levels and glycosylated hemoglobin (HbA1c) levels, concurrently contributing to a reduction in insulin requirements during medication therapy. Furthermore, short-term experiments have revealed a positive association between nutrition choices and weight management. Beneficial improvements have been noted in the lipid profiles, including high-density lipoprotein, low-density lipoprotein, HbA1c, and triglyceride levels. For individuals grappling with diabetes or obesity, a low-carbohydrate diet emerges as a genuine and potentially beneficial therapy option. This review provides a comprehensive overview of the key concepts influencing the treatment of obesity and Type 2 diabetic patients through low-carbohydrate diets.

Keywords
Keto diet
Type 2 diabetes
Obesity
Non-communicable disease
Funding
None.
References
  1. Bentham J, Di-Cesare M, Bilano V, et al., 2017, Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128 9 million children, adolescents, and adults. Lancet, 39: 2627–2642. https://doi.org/10.1016/S0140-6736(17)32129-3

 

  1. Powers MA, Bardsley JK, Cypress M, et al., 2020, Diabetes self-management education and support in adults with type 2 diabetes: A consensus report of the American diabetes association, the association of diabetes care and education specialists, the academy of nutrition and dietetics, the American academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care, 43: 1636–1649. https://doi.org/10.2337/dci20-0023

 

  1. Di Rosa C, Lattanzi G, Taylor SF, et al., 2020, Very low calorie ketogenic diets in overweight and obesity treatment: Effects on anthropometric parameters, body composition, satiety, lipid profile and microbiota. Obes Res Clin Pract, 14: 491–503. https://doi.org/10.1016/j.orcp.2020.08.009

 

  1. Pi-Sunyer X, 2009, The medical risks of obesity. Postgrad Med, 121: 21–33. https://doi.org/10.3810/pgm.2009.11.2074

 

  1. Li Zhang P, Wang J, An Y, et al., 2019, Effects of low-carbohydrate vs low-fat diets on cardiovascular risk factors,centers for disease control and prevention. Ann Intern Med, 140: 219–232.

 

  1. Hruby A, Hu FB, 2015, The epidemiology of obesity: A big picture. Pharmacoeconomics, 33: 673–689. https://doi.org/10.1007/s40273-014-0243-x

 

  1. Ding C, Bao Y, Bai B, et al., 2022, An update on the economic burden of type 2 diabetes mellitus in China. Expert Rev Pharmacoecon Outcomes Res, 22: 617–625. https://doi.org/10.1080/14737167.2022.2020106

 

  1. O’Connell JM, Manson SM, 2019, Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions. Diabetes Care, 42: 1609–1611. https://doi.org/10.2337/dci19-0017

 

  1. Afroz A, Hird TR, Zomer E, et al., 2020, The impact of diabetes on the productivity and economy of Bangladesh. BMJ Glob Heal, 5: e002420. https://doi.org/10.1136/bmjgh-2020-002420

 

  1. Zawudie AB, Daka DW, Teshome D, et al., 2022, Economic burden of diabetic mellitus among patients on follow-up care in hospitals of Southwest Shewa Zone, central Ethiopia. BMC Health Serv Res, 22: 1398. https://doi.org/10.1186/s12913-022-08819-0

 

  1. Merangin DI, Pattiselanno F, Mentansan G, et al., 2018, Short-term low-carbohydrate high-fat diet with or without post-meal walks on glycemic control and inflammation in type 2 diabetes: A randomized trial. Am Physiol Soc, 2: 2016–2020.

 

  1. Athinarayanan SJ, Adams RN, Hallberg SJ, et al., 2019, Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: A 2-year non-randomized clinical trial. Front Endocrinol (Lausanne), 10: 348. https://doi.org/10.3389/fendo.2019.00348

 

  1. Castellana M, Conte E, Cignarelli A, et al., 2020, Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Rev Endocr Metab Disord, 21: 5–16. https://doi.org/10.1007/s11154-019-09514-y

 

  1. Choi YJ, Jeon SM, Shin S, 2021, Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: A meta-analysis of randomized controlled trials. Nutrients, 12: 2005. https://doi.org/10.3390/nu12072005

 

  1. Longo M, Zatterale F, Naderi J, et al., 2019, Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci, 20: 2358. https://doi.org/10.3390/ijms20092358

 

  1. Ebbeling CB, Feldman HA, Klein GL, et al., 2018, Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: Randomized trial. BMJ, 36: k4583. https://doi.org/10.1136/bmj.k4583

 

  1. Dashti HM, Al-Zaid NS, Mathew TC, et al., 2005, Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol Cell Biochem, 286: 1–9. https://doi.org/10.1007/s11010-005-9001-x

 

  1. Hussain TA, Mathew TC, Dashti AA, et al., 2012, Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition, 228: 1016–1021. https://doi.org/10.1016/j.nut.2012.01.016

 

  1. Lord K, Magrath G, 2010, Use of the ketogenic diet and dietary practices in the UK. J Hum Nutr Diet, 23: 126–132. https://doi.org/10.1111/j.1365-277X.2010.01040.x

 

  1. Miranda MJ, Turner Z, Magrath G, 2012, Alternative diets to the classical ketogenic diet--Can we be more liberal? Epilepsy Res, 100: 278–285. https://doi.org/10.1016/j.eplepsyres.2012.06.007

 

  1. Kossoff EH, Dorward JL, 2008, The modified Atkins diet. Epilepsia, 49: 37–41. https://doi.org/10.1111/j.1528-1167.2008.01831.x

 

  1. Huttenlocher PR, Wilbourn AJ, Signore JM, 1971, Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology, 21: 1097–1103. https://doi.org/10.1212/wnl.21.11.1097

 

  1. Augustin K, Khabbush A, Williams S, et al., 2018, Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol, 17: 84–93. https://doi.org/10.1016/S1474-4422(17)30408-8

 

  1. Liu EH, Dilip C, Yeh TS, et al., 2013, Long-term relapse-free rurvival rate and predictive factors of idiopathic thrombocytopenic purpura in adults undergoing splenectomy. Biomed J, 36: 23–27. https://doi.org/10.4103/2319-4170.107158

 

  1. Furukawa K, Shigematus K, Iwase Y, et al., 2018, Clinical effects of one year of chemotherapy with a modified medium-chain triglyceride ketogenic diet on the recurrence of stage IV colon cancer. Lancent Neurol, 36: e15709–e15709. https://doi.org/10.101200/JCO20183615_suppl.e15709

 

  1. Barbosa-Yañez RL, Dambeck U, Li L, et al., 2018, Acute endothelial benefits of fat restriction over carbohydrate restriction in type 2 diabetes mellitus: Beyond carbs and fats. Nutrients, 10: 1859. https://doi.org/10.3390/nu10121859

 

  1. Erickson N, Boscheri A, Linke B, et al., 2017, Systematic review: Isocaloric ketogenic dietary regimes for cancer patients. Med Oncol, 34: 72. https://doi.org/10.1007/s12032-017-0930-5

 

  1. Feinman RD, Fine EJ, 2007, Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor Biol Med Model, 12: 27. https://doi.org/10.1186/1742-4682-4-27

 

  1. Szewczyk A, Białek A, Kukielczak A, et al., 2011, Ocena sposobu żywienia osób chorujących na cukrzycę typu 1 i 2 Evaluation of eating habits in a group of people with type 1 and 2 diabetes. Probl Hig Epidemiol, 9: 267–271.

 

  1. Worth J, Soran H, 2007, Is there a role for low carbohydrate diets in the management of type 2 diabetes? Qjm, 100: 659–6063. https://doi.org/10.1093/qjmed/hcm071

 

  1. Diana R, Atmaka DR, 2020, Ketogenic diet for weight loss and its implication on health: A literature study. Media Gizi Indones, 15: 184–190. https://doi.org/10.20473/mgi.v15i3.184-193

 

  1. Roehl K, Sewak SL, 2017, Practice paper of the academy of nutrition and dietetics: Classic and modified ketogenic diets for treatment of epilepsy. J Acad Nutr Diet, 117: 1279–1292. https://doi.org/10.1016/j.jand.2017.06.006

 

  1. Harvey KL, Holcomb LE, Kolwicz SC Jr., 2019, Ketogenic diets and exercise performance. Nutrients, 11: 2296. https://doi.org/10.3390/nu11102296

 

  1. Reichard GA Jr., Owen OE, Haff AC, et al., 1974, Ketone-body production and oxidation in fasting obese humans. J Clin Invest, 53: 508–515. https://doi.org/10.1172/JCI107584

 

  1. Evans M, Cogan KE, Egan B, 2017, Metabolism of ketone bodies during exercise and training: Physiological basis for exogenous supplementation. J Physiol, 595: 2857–2871. https://doi.org/10.1113/JP273185

 

  1. Sumithran P, Proietto J, 2008, Ketogenic diets for weight loss: A review of their principles, safety and efficacy. Obes Res Clin Pract, 2: I–II. https://doi.org/10.1016/j.orcp.2007.11.003

 

  1. Weber DD, Aminzadeh-Gohari S, Tulipan J, et al., 2020, Ketogenic diet in the treatment of cancer-Where do we stand? Mol Metab, 33: 102–121. https://doi.org/10.1016/j.molmet.2019.06.026

 

  1. Vanitallie TB, Nufert TH, 1967, Ketones: Metabolism’s ugly duckling. Mol Metab, 61: 20–18. https://doi.org/10.131/nr.2003.oct.327

 

  1. Paoli A, 2014, Ketogenic diet for obesity: Friend or foe? Int J Environ Res Public Health, 11: 2092–2107. https://doi.org/10.3390/ijerph110202092

 

  1. Halestrap AP, Wilson MC, 2012, The monocarboxylate transporter family--role and regulation. IUBMB Life, 64: 109–119. https://doi.org/10.1002/iub.572

 

  1. Abbasi J, 2018, Interest in the ketogenic diet grows for weight loss and type 2 diabetes. JAMA, 19: 215–217. https://doi.org/10.1001/jama.2017.20639

 

  1. Tigga NP, Garg S, 2020, Prediction of type 2 diabetes using machine learning classification methods. Procedia Comput Sci, 7: 706–716. https://doi.org/10.1016/j.procs.2020.03.336

 

  1. Gosmanov AR, Gosmanova EO, Dillard-Cannon E, 2014, Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes, 7: 255–264. https://doi.org/10.2147/DMSO.S50516

 

  1. Gravina G, Ferrari F, Nebbiai G, 2021, The obesity paradox and diabetes. Eat Weight Disord, 26: 1057–1068. https://doi.org/10.1007/s40519-020-01015-1

 

  1. Röder PV, Wu B, Liu Y, et al., 2016, Pancreatic regulation of glucose homeostasis. Exp Mol Med, 48: e219. https://doi.org/10.1038/emm.2016.6

 

  1. Czech MP, 2017, Insulin action and resistance in obesity and type 2 diabetes. Nat Med, 23: 804–814. https://doi.org/10.1038/nm.4350

 

  1. Hudish LI, Reusch JE, Sussel L, 2019, β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest, 129: 4001–4008. https://doi.org/10.1172/JCI129188

 

  1. Ormazabal V, Nair S, Elfeky O, et al., 2018, Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol, 17: 122. https://doi.org/10.1186/s12933-018-0762-4

 

  1. Back SH, Kaufman RJ, 2012, Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem, 81: 767–793. https://doi.org/10.1146/annurev-biochem-072909-095555

 

  1. Moon JS, Karunakaran U, Suma E, et al., 2020, The role of CD36 in type 2 diabetes mellitus: β-cell dysfunction and beyond. Diabetes Metab J, 44: 222–233. https://doi.org/10.4093/dmj.2020.0053

 

  1. Uddin MS, Tewari D, Sharma G, et al., 2020, Molecular mechanisms of ER stress and UPR in the pathogenesis of alzheimer’s disease. Mol Neurobiol, 57: 2902–2919. https://doi.org/10.1007/s12035-020-01929-y

 

  1. Burgos-Morón E, Abad-Jiménez Z, de Marañón AM, et al., 2019, Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: The battle continues. J Clin Med, 8: 1385. https://doi.org/10.3390/JCM8091385

 

  1. Newsholme P, Cruzat V, Arfuso F, et al., 2014, Nutrient regulation of insulin secretion and action. J Endocrinol, 21: R105-R120. https://doi.org/10.1530/JOE-13-0616

 

  1. Singh M, Kumar A, 2018, Risks associated with SGLT2 inhibitors: An overview. Curr Drug Saf, 13: 84–91. https://doi.org/10.2174/1574886313666180226103408

 

  1. Singh M, Sharma R, Kumar A, 2019, Safety of SGLT2 inhibitors in patients with diabetes mellitus. Curr Drug Saf, 14: 87–93. https://doi.org/10.2174/1574886314666190206164647

 

  1. Sami W, Ansari T, Butt NS, et al., 2015, Effect of diet counseling on type 2 diabetes mellitus. Int J Sci Technol Res, 4: 112–118.

 

  1. Davies MJ, D’Alessio DA, Fradkin J, et al., 2018, Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the european association for the study of diabetes (EASD). Diabetes Care, 41: 2669–2701. https://doi.org/10.2337/dci18-0033

 

  1. Westman EC, Yancy WS Jr., 2020, Using a low-carbohydrate diet to treat obesity and type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes, 27: 255–260. https://doi.org/10.1097/MED.0000000000000565

 

  1. Ahmed SR, Bellamkonda S, Zilbermint M, et al., 2020, Effects of the low carbohydrate, high fat diet on glycemic control and body weight in patients with type 2 diabetes: Experience from a community-based cohort. BMJ Open Diabetes Res Care, 8: e000980. https://doi.org/10.1136/bmjdrc-2019-000980

 

  1. Al-Goblan AS, Al-Alfi MA, Khan MZ, 2014, Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes, 7: 587–591. https://doi.org/10.2147/dmso.S67400

 

  1. Westman EC, Yancy WS Jr., Mavropoulos JC, et al., 2008, The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond), 5: 36. https://doi.org/10.1186/1743-7075-5-36

 

  1. Nielsen JV, Joensson EA, 2008, Low-carbohydrate diet in type 2 diabetes: Stable improvement of bodyweight and glycemic control during 44 months follow-up. Nutr Metab (Lond), 5: 14. https://doi.org/10.1186/1743-7075-5-14

 

  1. Yancy WS Jr., Foy M, Chalecki AM, et al., 2005, A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond), 2: 34. https://doi.org/10.1186/1743-7075-2-34

 

  1. Boden G, Sargrad K, Homko C, et al., 2005, Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med, 142: 403–412. https://doi.org/10.7326/0003-4819-142-6-200503150-00006

 

  1. Robertson A, Broom I, 2012, Low-carbohydrate diets, obesity and diabetes : A review. Nutr Metab, 23: 12–44.

 

  1. Gutierrez M, Akhavan M, Jovanovic L, et al., 1998, Utility of a short-term 25% carbohydrate diet on improving glycemic control in type 2 diabetes mellitus. J Am Coll Nutr, 17: 595–600. https://doi.org/10.1080/07315724.1998.10718808

 

  1. Walton CM, Perry K, Hart RH, et al., 2019, Improvement in glycemic and lipid profiles in type 2 diabetics with a 90-day ketogenic diet. J Diabetes Res, 2019: 8681959. https://doi.org/10.1155/2019/8681959

 

  1. Pilone V, Tramontano S, Renzulli M, et al., 2018, Metabolic effects, safety, and acceptability of very low-calorie ketogenic dietetic scheme on candidates for bariatric surgery. Surg Obes Relat Dis, 14: 1013–1019. https://doi.org/10.1016/j.soard.2018.03.018

 

  1. Myette-Côté É, Durrer C, Neudorf H, et al., 2018, The effect of a short-term low-carbohydrate, high-fat diet with or without postmeal walks on glycemic control and inflammation in type 2 diabetes: A randomized trial. Am J Physiol Regul Integr Comp Physiol, 315: R1210–R1219. https://doi.org/10.1152/ajpregu.00240.2018

 

  1. Hallberg SJ, McKenzie AL, Williams PT, et al., 2018, Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study. Diabetes, 9: 583–612. https://doi.org/10.1007/s13300-018-0373-9

 

  1. Wycherley TP, Brinkworth GD, Keogh JB, et al., 2010, Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J Intern Med, 267: 452–461. https://doi.org/10.1111/j.1365-2796.2009.02174.x

 

  1. Goday A, Bellido D, Sajoux I, et al., 2016, Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes, 6: e230. https://doi.org/10.1038/nutd.2016.36

 

  1. Tay J, Luscombe-Marsh ND, Thompson CH, et al., 2015, Comparison of low-and high-carbohydrate diets for type 2 diabetes management: A randomized trial. Am J Clin Nutr, 102: 780–790. https://doi.org/10.3945/ajcn.115.112581

 

  1. Daly ME, Paisey R, Paisey R, et al., 2022, Short-term effects of severe dietary carbohydrate-restriction advice in type 2 diabetes--a randomized controlled trial. Diabet Med, 23: 15–20. https://doi.org/10.1111/j.1464-5491.2005.01760.x

 

  1. Wheeler ML, Dunbar SA, Jaacks LM, et al., 2012, Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010. Diabetes Care, 35: 434–445. https://doi.org/10.2337/dc11-2216

 

  1. Kirk JK, Graves DE, Craven TE, et al., 2008, Restricted-carbohydrate diets in patients with type 2 diabetes: A meta-analysis. J Am Diet Assoc, 108: 91–100. https://doi.org/10.1016/j.jada.2007.10.003

 

  1. Jiang S, Yang J, 2022, Global translational medicine association of insulin-like growth factor-1 and estimated glomerular filtration rate in patients with type 2 diabetes mellitus. Diabet Med, 1: 33–39.

 

 

  1. Masko EM, Thomas JA 2nd, Antonelli JA, et al., 2010, Low-carbohydrate diets and prostate cancer: How low is “low enough”? Cancer Prev Res (Phila), 3: 1124–1131. https://doi.org/10.1158/1940-6207.CAPR-10-0071

 

  1. Nahleh Z, 2011, Breast cancer, obesity and hormonal imbalance: A worrisome trend. Expert Rev Anticancer Ther, 11: 817–819. https://doi.org/10.1586/era.11.67

 

  1. Evert AB, Dennison M, Gardner CD, et al., 2019, Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care, 42: 731–754. https://doi.org/10.2337/dci19-0014

 

  1. Kelly T, Unwin D, Finucane F, 2020, Low-carbohydrate diets in the management of obesity and type 2 diabetes: A review from clinicians using the approach in practice. Int J Environ Res Public Health, 17: 2557. https://doi.org/10.3390/ijerph17072557

 

  1. Yancy WS Jr., Olsen MK, Guyton JR, et al., 2004, A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann Intern Med, 140: 769–777. https://doi.org/10.7326/0003-4819-140-10-200405180- 00006/asset/images/large/6ff4.jpeg

 

  1. Dyson PA, Kelly T, Deakin T, et al., 2011, Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med, 28: 1282–12888. https://doi.org/10.1111/j.1464-5491.2011.03371.x

 

  1. Wong K, Raffray M, Roy-Fleming A, et al., 2021, Ketogenic diet as a normal way of eating in adults with type 1 and type 2 diabetes: A qualitative study. Can J Diabetes, 45: 137–143.e1. https://doi.org/10.1016/j.jcjd.2020.06.016

 

  1. Gardner F, Burton J, Klimes I, 2006, Randomised controlled trial of a parenting intervention in the voluntary sector for reducing child conduct problems: Outcomes and mechanisms of change. J Child Psychol Psychiatry, 47: 1123–1132. https://doi.org/10.1111/j.1469-7610.2006.01668.x

 

  1. Saslow LR, Daubenmier JJ, Moskowitz JT, et al., 2017, Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr Diabetes, 7: 304. https://doi.org/10.1038/s41387-017-0006-9

 

  1. Samaha FF, Iqbal N, Seshadri P, et al., 2020 A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med, 48: 2074–2081. https://doi.org/10.1056/nejmoa022637

 

  1. Fenercioglu AK, Saler T, Genc E, et al., 2010, The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in type 2 diabetes mellitus without complications. J Endocrinol Invest, 33: 118–124. https://doi.org/10.1007/bf03346565

 

  1. Yancy WS Jr., Olsen MK, Guyton JR, et al., 2004, A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann Intern Med, 140: 769–779. https://doi.org/10.7326/0003-4819-140-10-200405180-00006

 

  1. Li S, Lin G, Chen J, et al., 2022, The effect of periodic ketogenic diet on newly diagnosed overweight or obese patients with type 2 diabetes. BMC Endocr Disord, 22: 34. https://doi.org/10.1186/s12902-022-00947-2

 

  1. Bilsborough SA, Crowe TC, 2020, Low-carbohydrate diets: What are the potential short-and long-term health implications? Asia Pac J Clin Nutr, 12: 396–404.

 

  1. Czyzewska-Majchrzak Ł, Grzelak T, Kramkowska M, et al., 2014, The use of low-carbohydrate diet in type 2 diabetes-benefits and risks. Ann Agric Environ Med, 21: 320–326. https://doi.org/10.5604/1232-1966.1108597

 

  1. Di Cesare M, Bentham J, Stevens GA, et al., 2016, Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet, 26: 1377–1396. https://doi.org/10.1016/S0140-6736(16)30054-X

 

  1. Tzur A, Roberts BM, 2020, The ketogenic diet for bodybuilders and physique athletes. Strength Cond J, 42: 108–115. https://doi.org/10.1519/SSC.0000000000000573

 

  1. Dyson PA, 2008, A review of low and reduced carbohydrate diets and weight loss in type 2 diabetes. J Hum Nutr Diet, 21: 530–538. https://doi.org/10.1111/j.1365-277X.2008.00896.x

 

  1. Nordmann AJ, Nordmann A, Briel M, et al., 2020, Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials. Arch Intern Med, 166: 285–294. https://doi.org/10.1001/archinte.166.3.285

 

  1. Volek JS, Sharman MJ, 2019, Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. Obes Res, 12: 95–105. https://doi.org/10.1038/oby.2004.276
Conflict of interest
The authors declare that they have no competing interests.
Share
Back to top
Global Translational Medicine, Electronic ISSN: 2811-0021 Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept